2). Laboratory testing also enables Exogene to determine which TCRs to advance for use in T cell therapies. “Our high-throughput data generation capabilities enable the continuous improvement of ...
Several cost-effective point-of-care CD4 T-cell testing options are also already on the market, in order to improve access to CD4 T-cell monitoring, especially for rural patients, and to reduce ...
Several cost-effective point-of-care CD4 T-cell testing options are also already on the market, and may be used for decentralization. CD4 T-cell count monitoring is cost-effective when compared ...